Burn News and Research

RSS

People to gather for CUGH annual conference to discuss critical role of universities in global health

More than 600 people will gather for the Consortium of Universities for Global Health annual conference being held at the University of Washington in Seattle on September 19-21 to discuss the critical role of universities in global health. The conference is the largest university-based global health conference ever held.

10 Sep 2010

Obesity key lies in the brain: Study

According to a new international study led in Australia by the Monash Obesity and Diabetes Institute (MODI) at Monash University, high fat diets that lead to obesity and weight gain make the brain immune to signals that tell the body to stop eating and to burn energy.

9 Sep 2010

An overview on low-carbohydrate diets

Headlines make news, but don't read too much into current headlines about a recent study titled "Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality," published in the September 7, 2010, issue of Annals of Internal Medicine. Although the headlines may say the study suggests that long-term adherence to a low-carb diet based heavily on animal protein may reduce lifespan, Dr. Funga, who was the lead author of the study, says that her research "is not representative of popular low-carb eating plans

7 Sep 2010

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

As the summer comes to a close, I wanted to update you on the Company's accomplishments this year, which set the stage for an exciting fall. The first eight months of the year have been very successful, with the Company attaining many of its goals, despite a very difficult economic environment, which has created challenges for many small biotechnology companies. Today, IMUC is in its best financial position ever and well positioned to validate the success it achieved in a Phase I trial for ICT-107, its dendritic cell-based cancer vaccine product candidate.

3 Sep 2010

New antibacterial peptide effective against infections in burn or blast wounds

An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers.

2 Sep 2010

Unpleasant short term side-effects of sunburn dont put off sun-seeking Brits

The research - commissioned by Superdrug and Cancer Research UK as part of their joint campaign to encourage people to enjoy the sun safely this summer - highlights the worrying lengths sun-seeking Brits are prepared to go to in search of a tan.

31 Aug 2010

USAAC, HWCF enter partnership to support healthier lifestyle choices for young people

The U.S. Army Accessions Command (USAAC) and the Healthy Weight Commitment Foundation (HWCF) today announced a partnership aimed at countering the trend toward obesity among young people that could among other downsides diminish the pool of qualified young Americans available for military duty.

31 Aug 2010

Ten million face hunger in Central Africa; Niger flooding exacerbates food shortage, leaves 200,000 homeless

Flash floods have "worsened an already chronic humanitarian crisis caused by drought" in central Africa where aid agencies have warned that "10 million people are already facing severe food shortages, particularly in the landlocked countries of Chad and Niger, after a drought led to the failure of last year's crops," the Independent reports.

31 Aug 2010

Immunomedics 2010 fourth quarter revenue decreases to $0.7 million

Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal, antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported financial results for the fourth quarter and fiscal year ended June 30, 2010.

27 Aug 2010

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

ACCESS PHARMACEUTICALS, INC.,a biopharmaceutical company specializing in products for cancer and supportive care, announced that its Director of Chemistry and Quality, Dr. Ric Zarzycki will give an invited presentation today on the Company's Cobalamin nanoparticle technology at a thought-leadership symposium being held at the American Chemical Society's ("ACS") 240th National Meeting & Exposition, at Boston Convention and Exhibition Center in Boston, Massachusetts, August 22-26, 2010.

25 Aug 2010

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

UK scientists at the University of Oxford have discovered that vitamin D can affect the activity of more than 200 genes of cells grown in the lab. Some of these genes are known from previous studies to be involved in diseases like diabetes and cancer.

24 Aug 2010

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system. Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.

20 Aug 2010

Discovery on stem cell can create new opportunity in organ regeneration field

Taking one type of cell and transforming it into another type is now possible. Cells taken from the thymus have been transformed into skin cells,a discovery that may have important ramifications for the field of organ regeneration.

19 Aug 2010

University of Maryland researchers link 3-D CT scans to standard ablation techniques

Researchers at the University of Maryland School of Medicine in Baltimore have developed a novel 3-D imaging approach that may improve the accuracy of treatment for ventricular tachycardia, a potentially life-threatening heart rhythm disorder that causes the heart to beat too fast. The new approach couples CT images with conventional ablation techniques to eliminate erratic electrical circuits in the heart that produce arrhythmias.

19 Aug 2010

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) to extend the shelf life of Hizentra®, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months. Hizentra, the first and only 20 percent subcutaneous immunoglobulin (SCIg) approved in the U.S. by the FDA, is also the first and only SCIg in the U.S. that may be stored at room temperature.

19 Aug 2010

Tips for safe exercising in the heat

The record high temperatures that have dominated most of the summer are continuing to make outdoor activities more dangerous. Despite the extreme heat and humidity many people are exercising outside, knowing winter is just around the corner.

18 Aug 2010

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

ImmunoCellular Therapeutics today announced second quarter results for the period ended June 30, 2010. The Company utilized $1.13 million of cash in its operations during the quarter. The increase in net burn is reflective of increased personnel costs as well as increase in Research and Development costs associated with the planned phase II clinical trial for ICT-107.

18 Aug 2010

Discovery can lead to new class of drugs for chronic pain treatment

Researchers have made a discovery that could lead to a brand new class of drugs to treat chronic pain caused by inflammatory conditions such as arthritis and back pain without numbing the whole body.

17 Aug 2010

Diets rich in antioxidants, omega-3 fatty acids can help protect people from skin cancer: Study

We all want that summer glow that comes from a day at the beach, but taking in the rays can have long-term implications for our health. Now Dr. Niva Shapira of Tel Aviv University's School of Health Professions suggests a way to make fun in the sun safer ― and it's all in our food.

17 Aug 2010

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2010.

13 Aug 2010

Burn News and Research

People to gather for CUGH annual conference to discuss critical role of universities in global health

Obesity key lies in the brain: Study

An overview on low-carbohydrate diets

ImmunoCellular Therapeutics updates accomplishments in Letter to Shareholders

New antibacterial peptide effective against infections in burn or blast wounds

Unpleasant short term side-effects of sunburn dont put off sun-seeking Brits

USAAC, HWCF enter partnership to support healthier lifestyle choices for young people

Ten million face hunger in Central Africa; Niger flooding exacerbates food shortage, leaves 200,000 homeless

Immunomedics 2010 fourth quarter revenue decreases to $0.7 million

Access Pharmaceuticals to highlight Cobalamin nanotechnology at ACS National Meeting

Scientists discover influence of vitamin D in genes linked with autoimmune diseases

Fenwal's new software release for Autopheresis-C system receives FDA 510(k) clearance

Discovery on stem cell can create new opportunity in organ regeneration field

University of Maryland researchers link 3-D CT scans to standard ablation techniques

FDA approves CSL Behring's sBLA to extend shelf life of Hizentra from 18 to 24 months

Tips for safe exercising in the heat

ImmunoCellular Therapeutics raises $6.5 million in second quarter 2010

Discovery can lead to new class of drugs for chronic pain treatment

Diets rich in antioxidants, omega-3 fatty acids can help protect people from skin cancer: Study

Derma Sciences second-quarter net sales increase 14% to $13.2 million

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News